Form D · Biotechnology

CARI Health, Inc.

San Diego, CA · CIK 0001930994

Offering snapshot reported Nov 6, 2026 · SEC filing

Reported sold
$280K
Offering amount: $1M
Investors reported
7
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Jul 9, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$140K$280KJul 21, 2025: $100,000.00Jul 21, 2025Nov 6, 2026: $280,000.00Nov 6, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$100,000 → $280,000
  • Reported investors2 → 7

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 6, 2026Amendment$280,000$180,000vs Jul 21, 20257SEC filing
Jul 21, 2025Initial$100,000No comparison2SEC filing
Feb 15, 2024Initial$150,000No comparison2SEC filing
Feb 14, 2024Initial$2,300,000No comparison11SEC filing
May 26, 2022Initial$800,000No comparison4SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-552378
Convertible Promissory Notes

Source: Form D, filed Nov 6, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gioia Messinger Director
Charles Patton Director
Patrik Schmidle Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4653 Carmel Mountain Rd., S 308/260
San Diego, CA, 92130